focus -WSS

focus

author：hotspot 2025-08-26 03:42:32 - browse：799

John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT — John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Eye stem cell transplant could help restore vision in injured people

WSS

Listen: Racing for gene therapy & a pioneering approval

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Hilary expected to bring catastrophic, life

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Trump's false claims about Georgia's 2020 election long debunked

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

As demand for Covid shots wanes, Moderna seeks its next success

New definition of a human embryo proposed amid rapid advances

How to save PrEP access — and even expand it

Living with Hashimoto's and celiac disease, and med school, too

The cancer drug shortage isn’t new — and neither are the solutions

Evacuations in place as 3 wildfires burn in eastern Washington state

BioMarin wins approval for gene therapy to treat hemophilia A

Europe sees delivery challenges ahead on Alzheimer's therapies

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Grail faces three suits alleging harassment, retaliation

leisure time

Mike Pence clashes with Tucker Carlson in Iowa

New definition of a human embryo proposed amid rapid advances

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Clinical trials must include more disabled people

Congress likely to miss an opportunity to fix drug shortages issue

Involuntary treatment for addiction doesn't work

focus

entertainment

explore

hotspot